LEADER 01274nam2-2200397---450 
001 990006001470203316
005 20170316163316.0
010   $a978-0-470-77009-2
035   $a000600147
035   $aUSA01000600147
035   $a(ALEPH)000600147USA01
035   $a000600147
100   $a20030911d2010----km-y0enga50------ba
101 0 $aeng
102   $aUS
105   $aaf--z|||001yy
200 1 $a<<v. 8:>> CNS disorders$fedited by Donald J. Abraham, David P. Rotella
205   $a7. ed.
210   $aHoboken [etc.]$cJ. Wiley & Sons$dcopyr. 2010
215   $aIX, [1] c. di tav., 1020 p.$cill.$d26 cm
461  1$1001000600086$12001$aBurger's medicinal chemistry, drug discovery and development
606 1 $aChimica farmaceutica
676   $a615.19
702  1$aABRAHAM,$bDonald J.
702  1$aROTELLA,$bDavid P.
801  0$aIT$bSalbc$cISBD
856  4$uhttp://mrw.interscience.wiley.com/emrw/9780471266945/home/$4.$zaccessibile on-line
912   $a990006001470203316
951   $a615.19 BUR 8 8$b5769/H Farm.$c615$d00330472
951   $a615.19 BUR 8 8a$b2843/H Med.$c615$d00335991
959   $aBK
969   $aMED
969   $aFAR
979   $aPAOLA$b90$c20150128$lUSA01$h1601
996   $aCNS disorders$91078931
997   $aUNISA